720MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced gynecological cancers (Gynecol C): Results from a phase I studyJian Shu, Qi Zhou, Yunchao Huang et al.|Annals of Oncology|2024Cited by 6